Cytokine Regulation of Muscle Protein Synthesis During Infection

  • Lang, Charles (PI)
  • LANG, CHARLES (PI)
  • LANG, CHARLES (PI)
  • LANG, CHARLES (PI)
  • LANG, CHARLES (PI)

Project: Research project

Project Details

Description

DESCRIPTION (provided by applicant): Muscle wasting remains a cause of morbidity and mortality after trauma, burns and infection. Although the mechanisms for the atrophic response are multi-factorial and poorly defined, our work during the past funding period documents the causal relationship between the up regulation of inflammatory modulators, particularly TNF? and NO, and the decreased translational control of muscle protein synthesis. Further, we reported that sepsis impairs the responsiveness of skeletal muscle to nutrient (e.g., leucine) stimulation. This leucine (Leu) resistance results from suppression of mTOR kinase activity and inhibition of protein synthesis, and is Akt/TSC-independent. Our long-term goal is to elucidate the cellular and molecular mechanisms by which sepsis down-regulates nutritional signals and produces skeletal muscle myopathy, thereby validating specific proteins as potential therapeutic targets. Specifically, our overall objective is to identify Akt/TSC-independent mechanisms by which sepsis down-regulates nutritional signals and produces skeletal muscle myopathy. To address the questions implicit in this goal, the proposed research has the following specific aims: (1) Assess the importance of the sepsis-induced change in total and/or phosphorylated DEPTOR (a known mTOR negative regulatory protein) as a mechanism for the decrease in basal and/or Leu-stimulated muscle protein synthesis; (2) Determine the mechanism by which sepsis disrupts endosomal trafficking of mTOR complex-1 (mTORC1) and impairs amino acid sensing and protein synthesis in muscle; and (3) Elucidate the extent to which altered MAP4K3 signaling is mechanistically linked to the sepsis-induced decrease in mTORC1 activity under basal and nutrient-stimulated conditions. Our application exploits a number of innovative approaches made possible by the availability of novel reagents and supported by provocative preliminary data. While our focus on state-of-the-art in vivo approaches permits us to definitively assign physiological importance to our observations, complementary in vitro studies will allow us to define cellular mechanisms and to prioritize future work. It is noteworthy that the proposed in vivo electroporation of shRNA or over-expression plasmids specifically to skeletal muscle permits loss- and gain-of-function experiments to be performed, thereby assigning causality to the observed changes. Furthermore, changes in muscle mass/protein synthesis will be correlated with direct assessment of muscle contractility. These in vivo methods, used in conjunction with an established murine model of sepsis and with the availability of novel phospho-specific antibodies, place us in a unique position to rapidly and significantly advance knowledge pertaining to amino acid regulation of mTORC1 in both health and disease. The expected research outcomes will have a positive impact by contributing fundamental knowledge concerning nutrient regulation at the molecular level and providing seminal mechanistic insights into the clinically significant pathology of sepsis-induced myopathy which impedes recovery and rehabilitation.
StatusFinished
Effective start/end date7/1/925/31/17

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.